Background
Advanced age increases the risk for severe COVID-19. However, the risk factors for mortality from COVID-19 in very elderly patients (≥80-years-old) are unknown.
Objective
Investigate the relationship of mortality with the clinical characteristics of very elderly COVID-19 patients.
Materials and Methods
Very elderly patients who were hospitalized with COVID-19 from December 3, 2022 to January 1, 2023 were retrospectively examined. Sociodemographic and clinical variables were recorded and survival was recorded after 30 days.
Results
We examined 181 patients (median age: 90.84 years; 114 older than 90 years). The median Barthel index was 30.69, and 55.8% of patients had severe or critical COVID-19 pneumonia. Forty-two patients (33.2%) received a high-flow nasal cannula or non-invasive ventilation, and only 4.4% received mechanical ventilation. The overall mortality was 35.9%, and there was no significant difference in mortality for the 80 to 90-year-old group and the over 90-year-old group (37.7% vs 32.8%,
P
=0.508). A multivariate analysis showed that the Barthel index (OR, 0.975; 95% CI, 0.962–0.989), serum creatinine (SCr) level (OR, 1.003; 95% CI, 1.000–1.006), white blood cell (WBC) count (OR, 1.160; 95% CI, 1.056–1.276), D-dimer level (OR, 1.060; 95% CI, 1.009–1.113), and corticosteroid use (OR, 0.268; 95% CI, 0.124–0.582) were significantly and independently related to 30-day mortality. A binary classification model based on the multivariate analysis had good predictive value (area under the curve, 0.794).
Conclusion
Very elderly COVID-19 patients have a high risk for mortality. The Barthel index, SCr, WBC count, D-dimer level, and corticosteroid use were independently associated with mortality.